Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
J Pediatr Endocrinol Metab. 2021 Apr 12;34(6):679-696. doi: 10.1515/jpem-2021-0045. Print 2021 Jun 25.
Provocative growth hormone (GH) tests are widely used for diagnosing pediatric GH deficiency (GHD). A thorough understanding of the evidence behind commonly used interpretations and the limitations of these tests is important for improving clinical practice.
To place current practice into a historical context, the supporting evidence behind the use of provocative GH tests is presented. By reviewing GH measurement techniques and examining the early data supporting the most common tests and later studies that compared provocative agents to establish reference ranges, the low sensitivity and specificity of these tests become readily apparent. Studies that assess the effects of patient factors, such as obesity and sex steroids, on GH testing further bring the appropriateness of commonly used cutoffs for diagnosing GHD into question.
Despite the widely recognized poor performance of provocative GH tests in distinguishing GH sufficiency from deficiency, limited progress has been made in improving them. New diagnostic modalities are needed, but until they become available, clinicians can improve the clinical application of provocative GH tests by taking into account the multiple factors that influence their results.
激发生长激素(GH)试验被广泛用于诊断儿童生长激素缺乏症(GHD)。深入了解常用解释背后的证据以及这些试验的局限性对于改善临床实践非常重要。
为了将当前的实践置于历史背景下,本文介绍了使用激发 GH 试验的支持证据。通过回顾 GH 测量技术,并检查支持最常见试验的早期数据以及后来比较激发剂以建立参考范围的研究,可以明显看出这些试验的灵敏度和特异性较低。评估患者因素(如肥胖和性激素)对 GH 检测影响的研究进一步质疑了常用的诊断 GHD 截止值的适用性。
尽管激发 GH 试验在区分 GH 充足与缺乏方面表现不佳已得到广泛认可,但在改善这些试验方面进展甚微。需要新的诊断方式,但在这些方式可用之前,临床医生可以通过考虑影响其结果的多种因素来改善激发 GH 试验的临床应用。